8-K
filed February 27, 2026, 6:59 PM ET
ticker EONR
CIK 0001842556
other material
confidence high
sentiment negative
materiality 0.70
EON Resources restates 2023-2025 financials after SEC review of NCI accounting
EON Resources Inc.
- Audit committee determined financial statements for 2023, 2024, and quarterly periods in 2024-2025 should no longer be relied upon.
- 2023 net loss allocated to shareholders reduced from $9.0M to ~$6.7M after allocating $2.3M loss to NCI for Class B Equity.
- 2024 annual net loss to shareholders reduced from $9.1M to ~$7.5M after allocating $1.5M loss to NCI.
- Restatement is non-cash; total company net income/loss and cash flows unchanged.
- Amended 2024 10-K to be filed; 2025 quarterly impact to be included in upcoming 2025 10-K.
Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001213900-26-021741
- form_type
- 8-K
- ticker
- EONR
- cik
- 0001842556
- company_name
- EON Resources Inc.
- filed_at
- 2026-02-27T23:59:59+00:00
- discovered_at
- 2026-05-14T18:02:36.501005+00:00
- generated_at
- 2026-05-15T23:10:50.602118+00:00
- sec_items
- ["4.02"]
- event_type
- other_material
- sentiment
- negative
- materiality_score
- 0.7
- calibrated_materiality_score
- 0.7
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0001213900-26-021741
- json_url
- https://secwatch.observer/filing/0001213900-26-021741.json
- markdown_url
- https://secwatch.observer/filing/0001213900-26-021741.md
- text_url
- https://secwatch.observer/filing/0001213900-26-021741.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/1842556/000121390026021741/0001213900-26-021741-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/1842556/000121390026021741/f8k022426_eonresorces.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Comparable filings
GWLL
Goldenwell Biotech to restate three quarterly reports over $9,840 legal fee timing errors
GOLDENWELL BIOTECH, INC.
May 26, 2026, 8:17 PM ET
other_material
Items 4.02, 9.01
same fact type: auditor_change
same SEC item: 4.02
same event type: other_material
similar materiality
This filing
the Audit Committee also determined that the Company’s financial statements for the years ended December 31, 2023 and 2024, and in each of the Company’s quarterly reports on Form 10-Q filed with the SEC in 2024 and 2025 (collectively, the “Affected Periods”), should no longer be relied upon.
Comparable filing
the Company’s independent registered public accounting firm, Michael Gillsepie & Associates, PLLC (“Gillespie & Associates”), notified the Company that the Company did not follow US GAAP because an invoice dated September 23, 2025, from the Company’s legal counsel in the amount of $9,840 to the Company, which covered legal services rendered to the Company between May 21, 2024 and September 23, 2025, should have been recorded in the fiscal quarters when services were performed
Filing page
SEC filing
NMTC
NeuroOne restates Q1 FY2026 results due to revenue recognition error; reaffirms FY2026 guidance
NEUROONE MEDICAL TECHNOLOGIES Corp
May 22, 2026, 4:30 PM ET
other_material
Items 4.02, 7.01, 9.01
same fact type: auditor_change
same SEC item: 4.02
same event type: other_material
similar materiality
This filing
the Audit Committee also determined that the Company’s financial statements for the years ended December 31, 2023 and 2024, and in each of the Company’s quarterly reports on Form 10-Q filed with the SEC in 2024 and 2025 (collectively, the “Affected Periods”), should no longer be relied upon.
Comparable filing
On May 21, 2026, the Audit Committee (the “Audit Committee”) of the Board of Directors of NeuroOne Medical Technologies Corporation (the “Company”), after discussion with management, determined that the Company’s previously issued interim financial statements included in the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2026, filed on May 12, 2026 (the “Previous Filing”), should no longer be relied upon and should be restated because of accounting errors relating to revenue recognition.
Filing page
SEC filing
BGFR
BestGofer restates Q1 FY2026; goodwill impairment of $78,754 increases net loss to $85,755
BestGofer Inc.
May 19, 2026, 5:26 PM ET
other_material
Items 4.02, 2.06
same fact type: auditor_change
same SEC item: 4.02
same event type: other_material
similar materiality
This filing
the Audit Committee also determined that the Company’s financial statements for the years ended December 31, 2023 and 2024, and in each of the Company’s quarterly reports on Form 10-Q filed with the SEC in 2024 and 2025 (collectively, the “Affected Periods”), should no longer be relied upon.
Comparable filing
On May 5, 2026, the management of BestGofer, Inc. (the “Company”), in connection with the determination of a material non-cash impairment charge for the goodwill associated with the Company’s wholly-owned subsidiary, Liberty Home Inspection Services LLC (“LHIS”), concluded that the Company’s previously issued unaudited interim financial statements for the three months ended February 28, 2026, as filed with the Securities and Exchange Commission (the “SEC”) on April 22, 2026 in the Company’s Quarterly Report on Form 10-Q (SEC Accession No. 0001722556-26-000016) (the “Original Form 10-Q”), should no longer be relied upon.
Filing page
SEC filing
CGC
Canopy Growth restates FY2024-2025 financials due to warrant classification error; Q4/FY2026 results delayed to June 15
Canopy Growth Corp
May 15, 2026, 5:06 PM ET
other_material
Items 4.02, 7.01, 9.01
same fact type: auditor_change
same SEC item: 4.02
same event type: other_material
similar materiality
This filing
the Audit Committee also determined that the Company’s financial statements for the years ended December 31, 2023 and 2024, and in each of the Company’s quarterly reports on Form 10-Q filed with the SEC in 2024 and 2025 (collectively, the “Affected Periods”), should no longer be relied upon.
Comparable filing
the audit committee of the board of directors of the Company (the “Audit Committee”) was made aware of and, after discussion with senior management of the Company, concluded that the Company’s previously issued (i) audited consolidated financial statements for the fiscal year ended March 31, 2024, included in the Company’s Annual Report on Form 10-K for such fiscal year (the “2024 10-K”), (ii) audited consolidated financial statements for the fiscal year ended March 31, 2025, included in the Company’s Annual Report on Form 10-K for such fiscal year (the “2025 10-K”) and (iii) unaudited consolidated financial statements for the quarterly periods ended September 30, 2023, December 31, 2023, June 30, 2024, September 30, 2024, December 31, 2024, June 30, 2025, September 30, 2025, and December 31, 2025, included in the Company’s Quarterly Reports on Form 10-Q for such quarterly periods (collectively, the “Prior Financial Statements”), should no longer be relied upon
Filing page
SEC filing
GRBK
Green Brick restates 2023-2025 revenue/cost after audit committee finds accounting error
Green Brick Partners, Inc.
April 29, 2026, 7:59 PM ET
other_material
Items 4.02
same fact type: auditor_change
same SEC item: 4.02
same event type: other_material
similar materiality
This filing
the Audit Committee also determined that the Company’s financial statements for the years ended December 31, 2023 and 2024, and in each of the Company’s quarterly reports on Form 10-Q filed with the SEC in 2024 and 2025 (collectively, the “Affected Periods”), should no longer be relied upon.
Comparable filing
On April 27, 2026, the Audit Committee (the “Committee”) of the Board of Directors of Green Brick Partners, Inc. (the “Company”), concluded that residential units revenue in prior periods had been incorrectly reported on a gross basis and excluded closing cost incentives offered to homebuyers, including interest-rate buy-downs, which had previously been included in cost of residential units.
Filing page
SEC filing
LRHC
La Rosa to restate FY2024 & interim results; revenue overstated $10.8M due to agent/principal error
La Rosa Holdings Corp.
April 24, 2026, 7:59 PM ET
other_material
Items 4.02
same fact type: auditor_change
same SEC item: 4.02
same event type: other_material
similar materiality
This filing
the Audit Committee also determined that the Company’s financial statements for the years ended December 31, 2023 and 2024, and in each of the Company’s quarterly reports on Form 10-Q filed with the SEC in 2024 and 2025 (collectively, the “Affected Periods”), should no longer be relied upon.
Comparable filing
n this Current Report on Form 8-K with CBIZ CPAs P.C., the Company’s independent registered public accounting firm. 1 SIGNATURES Pursuant to the requirements of the Securities
Filing page
SEC filing
PREAXIA HEALTH CARE PAYMENT SYSTEMS INC.
PreAxia restates Aug 31, 2025 financials; stock award errors, material weakness
PREAXIA HEALTH CARE PAYMENT SYSTEMS INC.
April 21, 2026, 7:59 PM ET
other_material
Items 4.02, 9.01
same fact type: auditor_change
same SEC item: 4.02
same event type: other_material
similar materiality
This filing
the Audit Committee also determined that the Company’s financial statements for the years ended December 31, 2023 and 2024, and in each of the Company’s quarterly reports on Form 10-Q filed with the SEC in 2024 and 2025 (collectively, the “Affected Periods”), should no longer be relied upon.
Comparable filing
On April 9, 2026, the management of PreAxia Health care Payment Systems Inc., a Nevada corporation (the “Company”), identified material errors in the previously released financial statements for the three months ended August 31, 2025 (the “Non-Reliance Period”) and concluded that such financial statements should no longer be relied upon.
Filing page
SEC filing
RAIN
Rain Enhancement restates Q1-Q2 2025 financials over D&O insurance premium accounting error
Rain Enhancement Technologies Holdco, Inc.
April 14, 2026, 7:59 PM ET
other_material
Items 4.02
same fact type: auditor_change
same SEC item: 4.02
same event type: other_material
similar materiality
This filing
the Audit Committee also determined that the Company’s financial statements for the years ended December 31, 2023 and 2024, and in each of the Company’s quarterly reports on Form 10-Q filed with the SEC in 2024 and 2025 (collectively, the “Affected Periods”), should no longer be relied upon.
Comparable filing
On April 11, 2026, the audit committee (the “Audit Committee”) of the board of directors of Rain Enhancement Technologies Holdco, Inc., a Massachusetts corporation (the “Company”), in consultation with management, determined that the Company’s previously issued unaudited condensed consolidated financial statements contained in its (i) Quarterly Report on Form 10-Q as of and for the three months ended March 31, 2025, filed with the Securities and Exchange Commission (“SEC”) on May 15, 2025 and (ii) Quarterly Report on Form 10-Q as of and for the three and six months ended June 30, 2025, filed with the SEC on August 14, 2025 (the “Affected Periods”), should no longer be relied upon due to an error in the accounting for financed insurance premiums.
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.